Suppr超能文献

Chopart 截肢术:质疑长期以来作为糖尿病足感染手术选择的临床疗效。

Chopart Amputation: Questioning the Clinical Efficacy of a Long-standing Surgical Option for Diabetic Foot Infection.

机构信息

From the Department of Orthopaedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY.

出版信息

J Am Acad Orthop Surg. 2020 Aug 15;28(16):684-691. doi: 10.5435/JAAOS-D-19-00757.

Abstract

BACKGROUND

Diabetic foot ulcers with associated infection and osteomyelitis often lead to partial or complete limb loss. Determination of the appropriate level for amputation based on the patient's baseline physical function, extent of infection, vascular patency, and comorbidities can be challenging. Although Chopart amputation preserves greater limb length than more proximal alternatives such as Syme or below-the-knee amputations (BKA), challenges with wound healing and prosthesis fitting have been reported. We aimed to investigate the functional and clinical outcomes of Chopart amputation combined with tendon transfers.

METHODS

We identified patients who underwent Chopart amputations for diabetic foot infections by an academic orthopaedic group between August 2013 and September 2018. Subjects completed three Patient-Reported Outcomes Measurement Information Systems (PROMIS) instruments. Incidence of postoperative complications and change in patient-reported outcomes before and after surgery were recorded.

RESULTS

Eighteen patients with an average age of 60.8 (range, 44 to 79) years were identified. The mean follow-up was 22.8 months (range, 6.7 to 51.0). Seventeen of the 18 total patients developed postoperative wound complications. These lead to revision amputations in 10 Chopart amputees, consisting of two Syme and eight BKAs. Half of the Chopart patients never received a prosthesis because of delayed wound healing and revision amputation. PROMIS physical function (PF) (31.1 pre-op and 28.6 post-op), pain interference (63.1 pre-op and 59.4 post-op), and depression (53.0 pre-op and 54.8 post-op) did not show significant change (P-values = 0.38, 0.29, 0.72, respectively). Pre- and post-op the PROMIS physical function scores were well below the US average.

DISCUSSION

In our patient cohort, 94% of patients developed postoperative wound complication. Only 44% of patients ever successfully ambulated with a prosthesis after Chopart amputation, and the others (56%) required revision amputations such as a BKA. Even after wound healing, Chopart amputees may struggle with obtaining a prosthesis suitable for ambulation. Surgeons should exercise judicious patient selection before performing Chopart amputation.

LEVEL OF EVIDENCE

IV, Case Series.

摘要

背景

伴有感染和骨髓炎的糖尿病足溃疡常导致部分或完全肢体丧失。根据患者的基线身体功能、感染程度、血管通畅性和合并症来确定适当的截肢水平具有挑战性。虽然 Chopard 截肢术比 Syme 或膝下截肢术(BKA)等更靠近肢体近端的替代方法保留更长的肢体长度,但据报道,伤口愈合和假肢适配方面存在挑战。我们旨在研究 Chopard 截肢术联合肌腱转移的功能和临床结果。

方法

我们通过学术骨科小组在 2013 年 8 月至 2018 年 9 月期间确定了因糖尿病足感染而接受 Chopard 截肢术的患者。受试者完成了三个患者报告的结果测量信息系统(PROMIS)工具。记录术后并发症的发生率以及手术前后患者报告结果的变化。

结果

共确定了 18 名平均年龄为 60.8 岁(范围,44 至 79 岁)的患者。平均随访时间为 22.8 个月(范围,6.7 至 51.0)。18 名患者中,有 17 名发生术后伤口并发症。这些并发症导致 10 名 Chopard 截肢患者需要进行 revision 截肢,其中包括 2 名 Syme 和 8 名 BKA。由于伤口愈合延迟和 revision 截肢,一半的 Chopard 患者从未接受过假肢。PROMIS 身体功能(PF)(术前 31.1,术后 28.6)、疼痛干扰(术前 63.1,术后 59.4)和抑郁(术前 53.0,术后 54.8)没有显著变化(P 值分别为 0.38、0.29、0.72)。术前和术后的 PROMIS 身体功能评分远低于美国平均水平。

讨论

在我们的患者队列中,94%的患者发生了术后伤口并发症。只有 44%的 Chopard 截肢患者在接受截肢术后成功使用假肢行走,其余(56%)需要进行 revision 截肢,如 BKA。即使在伤口愈合后,Chopard 截肢患者也可能难以获得适合行走的假肢。外科医生在进行 Chopard 截肢术之前应谨慎选择患者。

证据水平

IV,病例系列。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验